Genmab A/S (GMAB): Price and Financial Metrics


Genmab A/S (GMAB)

Today's Latest Price: $22.28 USD

0.27 (1.23%)

Updated Nov 13 6:55pm

Add GMAB to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 328 in Biotech

See all "A" rated Strong Buy stocks

GMAB Daily Price Range
GMAB 52-Week Price Range

GMAB Stock Price Chart More Charts


GMAB Price/Volume Stats

Current price $22.28
Prev. close $22.01
Day low $22.16
Day high $22.35
50-day MA $20.69
200-day MA $18.45
52-week high $22.35
52-week low $13.64
Volume 110,800
Avg. volume 194,414
Dividend yield N/A
Market Cap 2.87B

Genmab A/S (GMAB) Company Bio


Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its portfolio includes two products, daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma; and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998 and is headquartered in Copenhagen, Denmark.





GMAB Latest News Stream


Event/Time News Detail
Loading, please wait...

GMAB Latest Social Stream


Loading social stream, please wait...

View Full GMAB Social Stream

GMAB Price Returns

1-mo 8.68%
3-mo 11.23%
6-mo 29.50%
1-year 58.80%
3-year N/A
5-year N/A
YTD 35.24%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4201 seconds.